CLBT – cellebrite di ltd. - ordinary shares (US:NASDAQ)

News

Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection Landscape
Is Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools? [Yahoo! Finance]
Cellebrite DI Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Craig Hallum from $23.00 to $24.00. They now have a "buy" rating on the stock.
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $21.00 to $22.00. They now have an "overweight" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com